Elbit is looking to provide goodwill help in the near term to MIT Startups on COVID-19 related efforts including medical devices design, prototyping, manufacturing, and engineering support. 20% of Elbit's business is in medical equipment, and can also help advice startups on readying their offering for FDA approval. MIT Startups are invited to apply for Zoom Meeting with Elbit’s Director of Research and Development,
Update - Looking for a few more startups to participate in the exhibit portion of the conference and interact with ILP Corporate Members in attendance.
[Looking for 8 Startups to Speak on Sept 22 at 2021 MIT Innovations in Management Conference (followed by Startup Lunch Exhibit)].
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Anglo American, a British mining company, is looking for startups in bio technology, rapid access, improved recovery, dry processing, mining legacy, sensor fusion, and EPC disruption.
Looking for 12 Startups to present their technology during Lighting Talks and participate at the lunch Exhibit on March 8, 2023 at the 2023 MIT Innovations in Management Conference.
P&G and AS Watson are looking for startup partnerships to build new, personalized, effortless, and cost-effective ways to enhance the overall shopper experience Online + Offline through the Guided Selling Challenge and the Social Commerce Challenge.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
David Shrier, CEO & founder, Distilled Identity